MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$558,594K
Cash and cash
equivalents
$174,927K
Accounts receivable, net
$59,601K
Short-term portion of
financial royalty assets
$22,792K
Inventory
$9,126K
Other current assets
$5,785K
Income taxes
receivable
$1,446K
Right-of-use assets
$7,223K
Property and equipment,
net
$3,571K
Other
$1,788K
Total current assets
$832,271K
Intangible assets, net
$225,438K
Long-term portion of
financial royalty assets,...
$196,877K
Other investments
$121,451K
Goodwill
$101,541K
Equity method
investments
$46,500K
Noncurrent derivative
assets
$15,632K
Other assets
$12,582K
Deferred income taxes,
net
$8,345K
Total assets
$1,560,637K
Total liabilities and
stockholders equity
$1,560,637K
Total stockholders
equity
$1,017,212K
Total liabilities
$543,425K
Retained earnings
$608,088K
Additional paid-in capital
$400,649K
Accumulated other
comprehensive income (loss)
$8,455K
Common stock, 0.001 par
value 60,000 shares...
$20K
2030 convertible
senior notes, net
$446,192K
Total current
liabilities
$37,447K
Deferred income taxes,
net
$36,019K
Other long-term
liabilities
$16,629K
Long-term operating lease
liabilities
$4,204K
Long-term contingent
liabilities
$2,934K
Accrued liabilities
$31,453K
Accounts payable
$3,238K
Income tax payable
$1,239K
Current operating lease
liabilities
$1,095K
Current contingent
liabilities
$287K
Other current
liabilities
$135K
Back
Back
Balance Sheet
source: myfinsight.com
LIGAND PHARMACEUTICALS INC (LGNYZ)
LIGAND PHARMACEUTICALS INC (LGNYZ)